These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34897446)

  • 1. The WHO FCTC's lessons for addressing the commercial determinants of health.
    McHardy J
    Health Promot Int; 2021 Dec; 36(Supplement_1):i39-i52. PubMed ID: 34897446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaching Outside the Comfort Zone: Realising the FCTC's Potential for Public Health Governance and Regulation in the European Union Comment on "The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?".
    Berteletti F
    Int J Health Policy Manag; 2018 May; 7(5):459-462. PubMed ID: 29764110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption: quasi-experimental evaluations using interrupted time series analysis and in-sample forecast event modelling.
    Hoffman SJ; Poirier MJP; Rogers Van Katwyk S; Baral P; Sritharan L
    BMJ; 2019 Jun; 365():l2287. PubMed ID: 31217191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking Steps Toward Coherent Global Governance of Alcohol: The Challenge and Opportunity of Managing Conflict of Interest.
    Collin J
    J Stud Alcohol Drugs; 2021 May; 82(3):387-394. PubMed ID: 34100707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global health, equity and the WHO Framework Convention on Tobacco Control.
    Collin J
    Glob Health Promot; 2010 Mar; 17(1 Suppl):73-5. PubMed ID: 20595357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Governance beyond governments: the role of NGOs in the implementation of the FCTC.
    Sparks M
    Glob Health Promot; 2010 Mar; 17(1 Suppl):67-72. PubMed ID: 20595356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.
    Weishaar H; Collin J; Smith K; Grüning T; Mandal S; Gilmore A
    PLoS Med; 2012; 9(6):e1001249. PubMed ID: 22745607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO FCTC as a Pioneering and Learning Instrument Comment on "The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?".
    Puska P
    Int J Health Policy Manag; 2018 Jan; 7(1):75-77. PubMed ID: 29325405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Chilling Example? Uruguay, Philip Morris International, and WHO's Framework Convention on Tobacco Control.
    Russell A; Wainwright M; Mamudu H
    Med Anthropol Q; 2015 Jun; 29(2):256-77. PubMed ID: 25331730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of Smoke-Free Policies: Stepping Up FCTC's Game.
    Tsampi A; Been JV; Bruijn M; Toebes B
    Eur J Health Law; 2022 Mar; 29(2):261-274. PubMed ID: 35303720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FCTC Turns 10: Lessons From the Fist Decade.
    Wipfli H
    J Epidemiol; 2016 Jun; 26(6):279-83. PubMed ID: 27180935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing sector representation of non-state actors within the World Health Organisation Framework Convention on Tobacco Control.
    Sircar NR; Yadav A; Bialous SA
    Glob Public Health; 2021 Jul; 16(7):1111-1121. PubMed ID: 32960751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing NCDs: Challenges From Industry Market Promotion and Interferences.
    Tangcharoensathien V; Chandrasiri O; Kunpeuk W; Markchang K; Pangkariya N
    Int J Health Policy Manag; 2019 May; 8(5):256-260. PubMed ID: 31204441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalizing Tobacco? The Politics of Trade, Investment, and Tobacco Control.
    Jarman H
    Milbank Q; 2019 Jun; 97(2):449-479. PubMed ID: 31099058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?
    Nikogosian H; Kickbusch I
    Int J Health Policy Manag; 2016 Dec; 5(12):683-685. PubMed ID: 28005547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From silos to policy coherence: tobacco control, unhealthy commodity industries and the commercial determinants of health.
    Hill SE; Johns P; Nakkash RT; Collin J
    Tob Control; 2022 Mar; 31(2):322-327. PubMed ID: 35241606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing impacts of the WHO FCTC on national legislations: A case study of the Republic of Korea.
    Lee SG
    Health Policy; 2017 Jun; 121(6):604-612. PubMed ID: 28410807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to expand corporate autonomy by the tobacco, alcohol and sugar-sweetened beverage industry: a scoping review of reviews.
    Hoe C; Weiger C; Minosa MKR; Alonso F; Koon AD; Cohen JE
    Global Health; 2022 Feb; 18(1):17. PubMed ID: 35164801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the WHO FCTC on tobacco control: perspectives from stakeholders in 12 countries.
    Craig L; Fong GT; Chung-Hall J; Puska P;
    Tob Control; 2019 Jun; 28(Suppl 2):s129-s135. PubMed ID: 31147481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From global agenda-setting to domestic implementation: successes and challenges of the global health network on tobacco control.
    Gneiting U
    Health Policy Plan; 2016 Apr; 31 Suppl 1(Suppl 1):i74-86. PubMed ID: 26253698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.